Virtu KCG Holdings’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Virtu KCG Holdings’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-305,798	Closed	-$2.74M	–	4213
2016 Q3	$2.74M	Buy	+305,798	New	+$2.17M	0.07%	207
2016 Q2	–	Sell	-13,722	Closed	-$63K	–	3711
2016 Q1	$63K	Buy	+13,722	New	+$55.2K	﹤0.01%	2416
2015 Q1	–	Sell	-10,526	Closed	-$111K	–	4549
2014 Q4	$111K	Sell	10,526 -8,374	-44%	-$81.8K	﹤0.01%	3178
2014 Q3	$181K	Buy	+18,900	New	+$193K	﹤0.01%	2971

Virtu KCG Holdings's RPTP Position: Q4 2016 in Review

Virtu KCG Holdings sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 305,798 shares — an estimated $2.74M sold.

Virtu KCG Holdings first reported a position in RPTP in Q3 2014 and held it in 4 quarters. The position peaked at $2.74M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Virtu KCG Holdings reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Virtu KCG Holdings sold 305,798 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $2.74M.
Virtu KCG Holdings first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 4 quarters.
Virtu KCG Holdings's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.74M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.